Skip to content

OptiMalVax

An EC Horizon 2020 Project
Menu
  • Home
    • Home Page
  • Background
    • Malaria Parasite Lifecycle
    • Global Malaria Burden
  • Approach
    • OptiMalVax Objectives
    • OptiMalVax Strategy
    • OptiMalVax Project Chart
    • OptiMalVax Organisation
    • Pre-Erythrocytic Malaria Vaccines
    • Blood-Stage Malaria Vaccines
    • Transmission Blocking Malaria Vaccines
    • Virus-like Particles
    • Collaborators

Collaborators

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 733273
Built with Make. Your friendly small business site builder.